Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ: RLYB )

0.9961 -0.0539 (-5.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rallybio Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
From Rallybio Corporation
Via Business Wire
Rallybio to Present at the 2022 Wells Fargo Healthcare Conference
From Rallybio Corporation
Via Business Wire
Rallybio Reports Second Quarter 2022 Financial Results
From Rallybio Corporation
Via Business Wire
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
From Rallybio Corporation
Via Business Wire
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
40 Stocks Moving In Friday's Mid-Day Session
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. 
Via Benzinga
Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer
From Rallybio Corporation
Via Business Wire
Rallybio to Present at Upcoming Investor Conferences in June
From Rallybio Corporation
Via Business Wire
58 Biggest Movers From Yesterday
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
Rallybio Reports First Quarter 2022 Financial Results
From Rallybio Corporation
Via Business Wire
Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
From Rallybio Corporation
Via Business Wire
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
From Rallybio Corporation
Via Business Wire
How Is The Market Feeling About Rallybio Corporation - Common Stock?
Rallybio Corporation - Common Stock's (NASDAQ:RLYB) short percent of float has fallen 14.21% since its last report. The company recently reported that it has 446.60 thousand... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to... 
Via Benzinga
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results
From Rallybio Corporation
Via Business Wire
Rallybio to Present at the Cowen 42nd Annual Health Care Conference
From Rallybio Corporation
Via Business Wire
Ami Bavishi Joins Rallybio to Lead Investor Relations and Corporate Communications
From Rallybio Corporation
Via Business Wire
52 Biggest Movers From Friday
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:... 
Via Benzinga
Rallybio Highlights Portfolio Advances and Outlines Expected Upcoming Milestones for 2022
From Rallybio Corporation
Via Business Wire
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
From Rallybio Corporation
Via Business Wire
Rallybio Corporation to Present at the 4th Annual Evercore ISI HealthCONx Conference
From Rallybio Corporation
Via Business Wire
Rallybio to Present at the Jefferies London Healthcare Conference
From Rallybio Corporation
Via Business Wire
70 Biggest Movers From Friday
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4... 
Via Benzinga
Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights
From Rallybio Corporation
Via Business Wire
91 Biggest Movers From Yesterday
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Gogo Inc. (NASDAQ: GOGO) shares climbed 37.6% to close at $16.82 on Tuesday after the company raised the long-term financial targets announced during Q4 2020 earnings.... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.